Abstract
Musculoskeletal injections are generally considered safe and beneficial procedures when performed according to the indications and avoiding cases with absolute contraindications such as known hypersensitivity to any component of the injection, cellulitis or broken skin, unstable coagulopathy, and intra-articular or osteochondral fractures. However, it is important to acknowledge that complications have been reported in the literature also without the presence of contraindications.
These complications can be classified into three groups. The first group comprises joint-related effects, such as pain flare, infection, pseudoseptic arthritis, and steroid arthropathy. The second group encompasses effects on surrounding tissues, including pericapsular calcification, tendon rupture, and skin alterations. The third group includes systemic effects resulting from the local injections. The absorption of corticosteroids following a local injection varies, and, in most cases, especially with accurate intra-articular administration, the systemic absorption of locally injected musculoskeletal corticosteroids is minimal. However, some potential systemic effects include Cushing syndrome and hyperglycemia, which can occur in both diabetic and nondiabetic patients. Facial flushing is a more common and self-limited consequence. Rarely, anaphylaxis or neuropsychiatric changes may occur.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stephens MB, Beutler AI, O’Connor FG. Musculoskeletal injections: a review of the evidence. Am Fam Physician. 2008;78(8):971–6.
Larghi MM, Grassi M, Placenza E, Faugno L, Cerveri P, Manzotti A. Septic arthritis following joint injections: a 17 years retrospective study in an Academic General Hospital. Acta Biomed. 2021;92(6):e2021308.
Geirsson ÁJ, Statkevicius S, Víkingsson A. Septic arthritis in Iceland 1990–2002: increasing incidence due to iatrogenic infections. Ann Rheum Dis. 2008;67(5):638–43.
Mohamed M, Patel S, Plavnik K, Liu E, Casey K, Hossain MA. Retrospective analysis of septic arthritis caused by intra-articular viscosupplementation and steroid injections in a single outpatient Center. J Clin Med Res. 2019;11(7):480–3.
García-Arias M, Balsa A, Mola EM. Septic arthritis. Best Pract Res Clin Rheumatol. 2011;25(3):407–21.
Rasmussen L, Bell J, Kumar A, et al. A retrospective review of native septic arthritis in patients: can we diagnose based on laboratory values? Cureus. 2020;12:6.
Mathews CJ, Coakley G. Septic arthritis: current diagnostic and therapeutic algorithm. Curr Opin Rheumatol. 2008;20(4):457–62.
Li SF, Cassidy C, Chang C, Gharib S, Torres J. Diagnostic utility of laboratory tests in septic arthritis. Emerg Med J. 2007;24(2):75–7.
Newman JH. Review of septic arthritis throughout the antibiotic era. Ann Rheum Dis. 1976;35(3):198–205.
Mathews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial septic arthritis in adults. Lancet. 2010;375(9717):846–55.
Sedrak P, Hache P, Horner NS, Ayeni OR, Adili A, Khan M. Differential characteristics and management of pseudoseptic arthritis following hyaluronic acid injection is a rare complication: a systematic review. J ISAKOS. 2021;6(2):94–101.
Leopold SS, Warme WJ, Pettis PD, Shott S. Increased frequency of acute local reaction to intra-articular hylan GF-20 (Synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg. 2002;84(9):1619–23.
Adams ME, Lussier AJ, Peyron JG. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Saf. 2000;23(2):115–30.
Marino AA, Waddell DD, Kolomytkin OV, Pruett S, Sadasivan KK, Albright JA. Assessment of immunologic mechanisms for flare reactions to Synvisc®. Clin Orthop Relat Res. 2006;442:187–94.
Dragomir CL, Scott JL, Perino G, Adler R, Fealy S, Goldring MB. Acute inflammation with induction of anaphylatoxin C5a and terminal complement complex C5b-9 associated with multiple intra-articular injections of hylan G-F 20: a case report. Osteoarthr Cartil. 2012;20(7):791–5.
Miller WT, Restifo RA. Steroid Arthropathy1. 1966;86(4):652–657. https://doi.org/10.1148/86.4.652.
Conti RJ, Shinder M. Soft tissue calcifications induced by local corticosteroid injection. J Foot Surg. 1991;30(1):34–7.
Hynes JP, Kavanagh EC. Complications in image-guided musculoskeletal injections. Skelet Radiol. 2022;51(11):2097–104.
Nichols AW. Complications associated with the use of corticosteroids in the treatment of athletic injuries. Clin J Sport Med. 2005;15(5):370–5.
Stout A, Friedly J, Standaert CJ. Systemic absorption and side effects of locally injected glucocorticoids. PM&R. 2019;11(4):409–19.
Horani MH, Silverberg AB. Secondary Cushing’s syndrome after a single epidural injection of a corticosteroid. Endocr Pract. 2005;11(6):408–10.
Common Injections in Sports Medicine: General Principles and Specific Techniques | Musculoskeletal Key.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Compagnoni, R., Ravaglia, R., Randelli, P. (2024). Contraindications and Potential Side Effects of Injections. In: Kocaoglu, B., Laver, L., Girolamo, L.d., Compagnoni, R. (eds) Musculoskeletal Injections Manual. Springer, Cham. https://doi.org/10.1007/978-3-031-52603-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-52603-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-52602-2
Online ISBN: 978-3-031-52603-9
eBook Packages: MedicineMedicine (R0)